✦ LIBER ✦

Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study

✍ Scribed by Gane, Edward J.; Pockros, Paul J.; Zeuzem, Stefan; Marcellin, Patrick; Shikhman, Anna; Bernaards, Coen; Zhou, Julian; Yetzer, Ellen S.; Ballester, Rosa; Dwyer, Cindy; Tong, Xiao; Nájera, Isabel; Bertasso, Anne; Hammond, Janet; Kindrick, Amy; Morcos, Peter N.; Smith, Patrick; Stancic, Saray; Shulman, Nancy S.

Book ID: 127274297
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 505 KB
Volume: 35
Category: Article
ISSN: 0106-9543
DOI: 10.1111/liv.12588

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1412 INTERFERON-FREE TREATMENT WITH A CO

1412 INTERFERON-FREE TREATMENT WITH A COMBINATION OF MERICITABINE AND DANOPREVIR/R WITH OR WITHOUT RIBAVIRIN IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED PATIENTS

✍ Gane, E.J.; Pockros, P.; Zeuzem, S.; Marcellin, P.; Shikhman, A.; Bernaards, C.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 83 KB

1218 HIGH SUSTAINED VIROLOGICAL RESPONSE

1218 HIGH SUSTAINED VIROLOGICAL RESPONSE (SVR) RATE AFTER DANOPREVIR FOR ONLY 14 DAYS ASSOCIATED WITH PEG-INTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE CHRONIC HCV GENOTYPE 1 PATIENTS

✍ Larrey, P.; Carenco, C.; Guyader, D.; Boyer, N.; Benhamou, Y.; Daniélou, H.; Pag 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

1177 RAPID AND SUSTAINED ACHIEVEMENT OF

1177 RAPID AND SUSTAINED ACHIEVEMENT OF UNDETECTABLE HCV RNA DURING TREATMENT WITH RITONAVIR-BOOSTED DANOPREVIR/PEG-IFNa-2A/RBV IN HCV GENOTYPE 1 OR 4 PATIENTS: DAUPHINE WEEK 12 INTERIM ANALYSIS

✍ Everson, G.; Cooper, C.; Hezode, C.; Shiffman, M.L.; Yoshida, E.; Beltran-Jarami 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR

12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS

✍ D.R. Nelson; E. Lawitz; V. Bain; N. Gitlin; T. Hawkins; P. Marotta; K. Workowski 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 127 KB

ABT-450, Ritonavir, Ombitasvir, and Dasa

ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection

✍ Andreone, Pietro; Colombo, Massimo G.; Enejosa, Jeffrey V.; Koksal, Iftihar; Fer 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 709 KB

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE

1192 HIGH SUSTAINED VIROLOGICAL RESPONSE RATES WITH RESPONSE-GUIDED DANOPREVIR PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE, HCV GENOTYPE 1 PATIENTS: ATLAS STUDY FINAL RESULTS

✍ Marcellin, P.; Cooper, C.; Balart, L.A.; Larrey, D.G.; Box, T.D.; Yoshida, E.; L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB